CONTRAINDICATIONS
Zemaira is contraindicated in individuals with a known hypersensitivity to any of its components. Zemaira is also contraindicated in individuals with a history of anaphylaxis or severe systemic response to A1-PI products.
Individuals with selective IgA deficiencies who have known antibodies against IgA (anti-IgA antibodies) should not receive Zemaira, since these patients may experience severe reactions, including anaphylaxis, to IgA that may be present in Zemaira.
|